Notice of Proposed Sale · 144
Ovid Therapeutics Inc.
OVIDNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- OVID THERAPEUTICS INC.
- Issuer CIK
- 0001636651
- SEC file number
- 001-38085
- Phone
- (646) 661-7661
- Person for whose account securities are to be sold
- Jeffrey A. Rona
- Relationships to issuer
- Affiliated Stockholder
- Street
- 441 NINTH AVENUE
- Street (continued)
- 14TH FLOOR
- City
- NEW YORK
- State / country code
- NY
- Postal code
- 10001
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common Stock | 150,000 | 420,000 | 195,297,857 | 08/14/2026 | Nasdaq | Morgan Stanley |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley
- Street
- 1585 Broadway
- City
- New York
- State / country code
- NY
- Postal code
- 10036
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common Stock | 03/20/2022 | ESPP Purchase | Issuer | 2,541 | N | 03/20/2022 | Cash |
| Common Stock | 03/20/2023 | ESPP Purchase | Issuer | 4,428 | N | 03/20/2023 | Cash |
| Common Stock | 09/20/2023 | ESPP Purchase | Issuer | 3,672 | N | 09/20/2023 | Cash |
| Common Stock | 02/22/2024 | Restricted Stock Units | Issuer | 18,844 | N | 02/22/2024 | Compensation |
| Common Stock | 03/20/2024 | ESPP Purchase | Issuer | 3,115 | N | 03/20/2024 | Cash |
| Common Stock | 09/20/2024 | ESPP Purchase | Issuer | 5,000 | N | 09/20/2024 | Cash |
| Common Stock | 02/20/2025 | Restricted Stock Units | Issuer | 14,876 | N | 02/20/2025 | Compensation |
| Common Stock | 03/20/2025 | ESPP Purchase | Issuer | 5,000 | N | 03/20/2025 | Cash |
| Common Stock | 09/19/2025 | ESPP Purchase | Issuer | 5,000 | N | 09/19/2025 | Cash |
| Common Stock | 03/20/2026 | ESPP Purchase | Issuer | 2,499 | N | 03/20/2026 | Cash |
| Common Stock | 08/14/2026 | Stock Option Exercise | Issuer | 85,025 | N | 08/14/2026 | Cash |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 08/14/2026
- Signed
- /s/ Jeffrey Rona
Recent company filings
- SCHEDULE 13G/A - filed by Affinity Asset Advisors, LLC regarding Ovid Therapeutics Inc.Aug 13, 2026
- 10-Q filingAug 13, 2026
- Financial Statements and ExhibitsAug 13, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJul 8, 2026
- Submission of Matters to a Vote of Security HoldersJun 11, 2026